Track the 제일바이오 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 제일바이오 has recorded 35 insider filings. The latest transaction was filed on 24 February 2026 (Purchase). Among the most active insiders: 심광경. All data is openly available.
35
Insider Decl.
n/a
Thresholds
n/a
16 ops.
Buy Volume
n/a
4 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.